The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com.

• Allergy Testing
• Aqueous Shunts and Stents for Glaucoma
• Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies (Former Title: Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies)
• Esophageal pH Monitoring
• Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
• Genetic Testing Services
• Lysis of Epidural Adhesions
• Non-Wearable Automatic External Defibrillators (AED)
• Peripheral Artery Disease (PAD) Rehabilitation
• Prior Authorization Via Web-Based Tool for Durable Medical Equipment (DME)
• Prior Authorization Via Web-Based Tool for Procedures
• Semi and Fully Implantable Middle Ear Hearing Aid
• Sphenopalatine Ganglion Block for Headache
• TEMPORARY Cost Share Waiver for Treatment of Confirmed Cases of COVID-19 During the COVID-19 Crisis
• Transesophageal Endoscopic Treatments for Gastroesophageal Reflux Disease
• Vertebral Fracture Assessment

We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the drop-down “Draft Medical Policies."